Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...

Insitro has teamed up with Eli Lilly to help power programs into the clinic, tapping the Big Pharma for an option on ...

The latest deal in AI drug discovery is a twist on the usual big pharma-startup collaboration model, with Insitro licensing ...

In a departure from most deals, startup insitro will in-license Lilly’s delivery technology for its investigational ...

Eli Lilly headquarters in Indianapolis.Pharmaceutical giant Eli Lilly (LLY) is putting $4.5 billion toward building a new ...

As that figure was large, weight loss drug producer Eli Lilly (NYSE: LLY) saw a nearly 2% bump in its share price in response ...

As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of powerhouse rival Johnson & Johnson largely thanks to its diabetes and ...

Thomas Fuchs will lead AI initiatives across Lilly, including in drug discovery, clinical trials and manufacturing.

Eli Lilly’s investment in the LEAP Research and Innovation District in Lebanon, Indiana, has now jumped to more than $13 ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY – Research ...